COLPOSCOPY QUALITY CONTROL GROUP FOR THE ASCUS/LSIL CLINICALMANAGEMENT TRIAL



NIH GUIDE, Volume 23, Number 40, November 18, 1994



RFP AVAILABLE:  NCI-CN-55042-07



P.T. 34



Keywords:

  Cancer/Carcinogenesis 

  Instrumentation, Medical 

  Clinical Trial 



National Cancer Institute



The National Cancer Institute, Division of Cancer Prevention and

Control, is soliciting proposals for a Colposcopy Quality Control

(QC) Group that will be responsible for overseeing all aspects of

randomized clinical trial involving colposcopy and the taking of

cervical biopsies among 3,600 women with the cervical cytologic

diagnoses of "atypical squamous cells of undetermined significance"

(ASCUS) and 3,600 women with "low-grade squamous intra-epithelial

lesions" (LSIL).  The Colposcopy QC Group shall be responsible for

overseeing the quality of all aspects of the Trial involving

colposcopies and the taking of cervical biopsies.  The general

requirements include: (1) preparation with the other collaborators of

the final protocols, data systems, and study forms; specifically,

identifying the optimal means to assure the highest possible quality

of colposcopic examinations and cervical biopsies; (2) prior to

enrollment, optimizing and standardizing clinic colposcopic and

biopsy procedures, equipment, and supplies; (3) during the conduct of

the Trial, monitoring and optimizing all aspects of the Protocol

related to colposcopy and biopsies including the design and conduct

of experiments to assess the accuracy of colposcopic examinations,

particularly the assessment of lesion severity and placement of

biopsies; (4) ongoing participation in the overall supervision of the

Trial via the Steering Committee and its subcommittees; and (5)

cooperation with all Trial administrative functions, including

reporting, data management, and proper handling of Trial-related

biospecimens.  Requests for this solicitation must be in writing and

reference the RFP Number.



INQUIRIES



Requests for this solicitation must be in writing and reference the

RFP Number, NCI-CN-55042-07.  The RFP is tentatively scheduled for

release on December 1, 1994 and proposals will be due approximately

January 30, 1995.  No collect calls will be accepted.  Requests

should be mailed to:



Victor S. Buyny

Research Contracts Branch, PCCS

National Cancer Institute

Executive Plaza South, Room 635

6120 Executive Boulevard, MSC 7226

Bethesda, MD  20892-7226

Telephone:  (301) 496-8603



.


Return to 1994 Index

Return to NIH Guide Main Index


Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS)
  USA.gov - Government Made Easy


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.